The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Polymorphisms Associated With Circulating Sex Hormone Levels in Postmenopausal Women
Abstract
BACKGROUND: Reports suggest a relationship between circulating sex hormone levels and breast cancer risk, but genetic association studies have been inconclusive. We investigated the association between levels of sex hormones and single nucleotide polymorphisms (SNPs) in genes coding for the enzymes that regulate them. METHODS: We assayed circulating levels of estradiol, testosterone, estrone, androstenedione, 17alpha-hydroxyprogesterone, and sex hormone-binding globulin (SHBG) in 1975 normal postmenopausal women. Fifteen SNPs in the CYP17, CYP19, EDH17B2, SHBG, COMT, and CYP1B1 genes were genotyped in these postmenopausal women and in a breast cancer case-control study. Associations of genotypes with breast cancer risk were evaluated in the case-control study and with hormone levels in the postmenopausal women using multiple linear regression with assay batch, body mass index, parity, peri- or postmenopausal status, and age band as covariates. RESULTS: CYP19 SNPs (rs10046 and [TCT]+/-) were associated with differences in estradiol level (P =.0006 and P =.0003, respectively) and the estradiol : testosterone ratio (P =.000001() and P =.002). SNP rs10046 explained 1.6% of the variance (r2) in the estradiol : testosterone ratio. SHBG SNPs (5' untranslated region [5'UTR] g-a and D356N) were associated with both SHBG levels (P<10(-6) and P =.005) and the estradiol : SHBG ratio (P =().000008() and P =.01). These SNPs explained 2.4% and 0.6% of the variance in SHBG levels, respectively. SNPs in the other genes were not associated with differences in any hormone levels, and none were statistically significantly associated with breast cancer risk. CONCLUSION: Genetic variation in CYP19 and SHBG contributes to variance in circulating hormone levels between postmenopausal women, but low r2 values may explain why these genes have given inconclusive results in breast cancer case-control studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Federation Proceedings: Water and Electrolyte Losses in Cholera
Phillips, R. A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1982.tb05283.x · Cited by 3,934
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
Handbook of Human Genetic Linkage.
Edwards, A. W. F., Terwilliger, J. D., & Ott, J. (1996) · Biometrics · doi:10.2307/2533082 · Cited by 869
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Self-citation(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Thomas, H., Key, T., Allen, D., Moore, J., Dowsett, M., Fentiman, I., & Wang, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.398 · Cited by 289
Self-citationChapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
Jefcoate, C. R., Liehr, J. G., Santen, R. J., Sutter, T. R., Yager, J. D., Yue, W., Santner, S. J., Tekmal, R., Demers, L., Pauley, R., et al. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024248 · Cited by 260
Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.
Jj, L., & Li, S. A. (1987) · PubMed · Cited by 243
Dowsett, M., Goss, P. E., Powles, T., Hutchinson, G., Brodie, A. M., Jeffcoate, S. L., & Coombes, R. C. (1987) · PubMed · Cited by 238
Self-citationThe relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
Haiman, C. A., Hankinson, S. E., Spiegelman, D. L., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, K. T., & Hunter, D. J. (1999) · PubMed · Cited by 212
Genetic variants of CYP19 (aromatase) and breast cancer risk
Kristensen, V. N., Harada, N., Yoshimura, N., Haraldsen, E., Lønning, P. E., Erikstein, B., Kåresen, R., Kristensen, T., & Børresen-Dale, A.-L. (2000) · Oncogene · doi:10.1038/sj.onc.1203425 · Cited by 166
SEGALOFF, A. (1966) · Proceedings of the 1965 Laurentian Hormone Conference · doi:10.1016/b978-1-4831-9825-5.50012-9 · Cited by 166
Significance of aromatase activity in human breast cancer.
Miller, W. R., Hawkins, R. A., & Forrest, A. P. M. (1982) · PubMed · Cited by 153
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort
Haiman, C. A., Stram, D. O., Pike, M. C., Kolonel, L. N., Burtt, N. P., Altshuler, D., Hirschhorn, J., & Henderson, B. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg294 · Cited by 150
Aromatase and breast cancer susceptibility.
Probst-Hensch, N. M., Ingles, S. A., Diep, A. T., Haile, R. W., Stanczyk, F. Z., Kolonel, L. N., & Henderson, B. E. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060165 · Cited by 146
The international variation in breast cancer rates: An epidemiological assessment
Henderson, B. E., & Bernstein, L. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf02633520 · Cited by 103
Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk
Healey, C. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.189 · Cited by 88
Self-citationCousin, P., Déchaud, H., Grenot, C., Lejeune, H., PUGEAT, M. M., Baret, C., & Brébant, C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4515 · Cited by 80
Inoue, K., Asao, T., & Shimada, T. (2000) · Xenobiotica · doi:10.1080/004982500237677 · Cited by 69
Mannermaa, A., Peltoketo, H., Winqvist, R., Ponder, B. A. J., Kiviniemi, H., Easton, D. F., POUTANEN, M. H., ISOMAA, V. V., & Vihko, R. (1994) · Human Genetics · doi:10.1007/bf00212030 · Cited by 58
Self-citationCousin, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.235 · Cited by 55
No association between a single nucleotide polymorphism in CYP19 and breast cancer risk.
Haiman, C. A., Hankinson, S. E., Spiegelman, D. L., Brown, M. A., & Hunter, D. J. (2002) · PubMed · Cited by 43
Cited by
Sex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726
A genome-wide association study identifies protein quantitative trait loci (pQTLs)
Melzer, D., Perry, J. R. B., Hernandez, D., Corsi, A.-M., Stevens, K., Rafferty, I., Lauretani, F., Murray, A., Gibbs, J. R., Paolisso, G., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000072 · Cited by 480
A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications
Goldman, A. L., Bhasin, S., Wu, F. C. W., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00025 · Cited by 414
Goedert, J. J., Jones, G., Hua, X., Xu, X., Yu, G., Flores, R., Falk, R. T., Gail, M. H., Shi, J., Ravel, J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv147 · Cited by 393
Brand, J. S., van der Tweel, I., Grobbee, D. E., Emmelot-Vonk, M. H., & van der Schouw, Y. T. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq158 · Cited by 334
Metadata
- Authors
- Dunning, A. M., Dowsett, M., Healey, C. S., Tee, L., Luben, R. N., Folkerd, E., Novik, K. L., Kelemen, L., Ogata, S., Pharoah, P. D. P., Easton, D. F., Day, N. E., & Ponder, B. A. J.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-06-15
- Volume
- 96
- Issue
- 12
- Pages
- 936-945
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2170137499
- Cited by
- 346
- References
- 24
- FWCI
- 14.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.